An error occured. Details Hide
You have unsaved pages. Restore Cancel

Pfizer

Balance Sheet (millions of US Dollars in 1st quarter 2019)
Assets 155,421 ADVFN
Liabilities 0 ADVFN
Balance Sheet Assets (millions of US Dollars in 1st quarter 2019)
Current Assets 45,290 ADVFN
Cash and Equivalents 1,937 ADVFN
Balance Sheet Liabilities (millions of US Dollars in 1st quarter 2019)
Equity 58,806 ADVFN
Current Liabilities 29,423 ADVFN
Income Statement
Basic EPS 0.69 US dollars in 1st quarter 2019 ADVFN
Cost of Sales with Depreciation 2,433 millions of US Dollars in 1st quarter 2019 ADVFN
Depreciation 0 millions of US Dollars in 1st quarter 2019 ADVFN
Diluted EPS 0.68 US dollars in 1st quarter 2019 ADVFN
DPS 0.36 US dollars in 1st quarter 2019 ADVFN
EBIT 4,684 millions of US Dollars in 1st quarter 2019 ADVFN
EBITDA 6,229 millions of US Dollars in 1st quarter 2019 ADVFN
Net Income 3,884 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Income 4,460 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Profit after Depreciation 6,229 millions of US Dollars in 1st quarter 2019 ADVFN
Pre-Tax Income 4,323 millions of US Dollars in 1st quarter 2019 ADVFN
Revenue 13,118 millions of US Dollars in 1st quarter 2019 ADVFN
Income Statement Revenue Revenue (millions of US Dollars in 1st quarter 2019)
Domestic 0 ADVFN
Foreign 0 ADVFN
Cash Flow Statement
Cash Flow 22,209 millions of US Dollars in 2012 ADVFN

Our Privacy Statement & Cookie Policy

Our website uses cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your personal cookie settings through your internet browser settings.

Privacy Policy